scholarly journals Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells

2019 ◽  
Vol 82 (2) ◽  
pp. 158 ◽  
Author(s):  
Jin-Soo Park ◽  
Hyun Kuk Kim ◽  
Eun-Young Kang ◽  
RyeonJin Cho ◽  
Yeon-Mok Oh
2018 ◽  
Vol 1 (70) ◽  
pp. 121-128
Author(s):  
Сергей Целуйко ◽  
Sergey Tseluyko ◽  
А Яценко ◽  
A Yacenko ◽  
Е Устинов ◽  
...  

Current methods of treatment of chronic obstructive pulmonary disease are not effective enough and lead to the progression of the disease and disability of the patient. One of the promising methods of chronic obstructive pulmonary disease therapy is the use of the possibilities of regenerative medicine, in particular, mesenchymal stem cells. The review demonstrates the achievements of research groups developing approaches to chronic obstructive pulmonary disease therapy based on mesenchymal stem cells. Our attention was focused on the problems and possible ways to show the mechanism of action of mesenchymal stem cells. The issues of safety of mesenchymal stem cells application are also discussed.


Sign in / Sign up

Export Citation Format

Share Document